Followers | 27 |
Posts | 3920 |
Boards Moderated | 0 |
Alias Born | 01/02/2003 |
Friday, April 30, 2021 9:55:31 PM
That said, pdsb burns very little cash annually. They have been great at generating non dilutive cash through investigator sponsored trials and I believe (hope) they will continue to do so going forward. They know what will be presented at ASCO in early June and know what the abstract will show in less than 3 weeks. I really don't anticipate a raise before then because I am very optimistic the ONLY reason we have an ORAL presentation is because the data is better than expected. Assuming I am right, the next raise will come well into double digits and dilution will be minimal.
On top of the known upcoming ASCO news, we could/should get Anvisa news any day. Even though it is Brazil, assuming we get approval to start the trial, we are off to the races.
PDSB has a market cap of less than $150 million. Any good news drives this to half a billion to a billion dollars almost overnight. That translates into $20-40/share from $5 and change. Crazy to think these types of returns are possible in only a few weeks/months. Looking out 6-12 months and you can easily see a case for 2 billion or more market cap with the right news. That is nuts and possible.
Granted, the likelihood is low based on experience of other companies but right now, based on what we know, the above is definitely possible. Today's investors can get rich off pdsb if the science proves out.
GLTA. It is my 3rd largest investment at the current time and I believe in months it will be my largest investment based on future growth that could come in an instant. HODL
Recent PDSB News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 12:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:05:43 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 08:39:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:13:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:45:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 12:05:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:16:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:05:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:33:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 10:10:16 PM
- PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 01/22/2024 09:45:19 PM
- PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/04/2023 09:50:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:02:38 PM
- PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer • GlobeNewswire Inc. • 11/28/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 11:02:46 AM
- PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 12:30:55 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM